Genedata Wins Swiss Biotech Success Story Award
Basel-headquartered developer of advanced software solutions recognized for success in digitalization of the global biotech industry
May 3, 2022
Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that the company has won the Swiss Biotech Success Story Award in recognition of outstanding achievement and contribution to the global biotech industry.
“We are very honored to be recognized by the Swiss Biotech Association and the timing could not be better. This month actually marks our 25th year in business and winning this prestigious award gives us even more reason to celebrate,” said Othmar Pfannes, Ph.D., Founder & CEO of Genedata. “Having roots in Basel, in the heart of the most important biopharmaceutical hub in Europe, has definitely helped us to grow our business globally. Today, the world’s leading biopharma R&D organizations are building their critical R&D operations on our software platform so they can efficiently process petabytes of data and bring precision medicines to patients faster and more efficiently. We are excited to drive this digital revolution here from Switzerland and from our offices around the world.”
The Swiss Biotech Success Story Award recognizes Genedata’s leadership role in creating enterprise software for biopharmaceutical and related industries. The Genedata Biopharma Platform is the market-leading solution to automate and industrialize biopharmaceutical R&D processes enabling a digital revolution to discover and develop novel therapeutic modalities such as cell and gene therapies (CGT) and innovative RNAs. Incorporating extensive biopharma R&D domain knowledge and artificial intelligence approaches, Genedata software helps biopharmaceutical organizations optimize workflows, increase research automation, improve experimental data quality, and maximize the ROI in R&D expenditure.
Founded in 1997, Genedata is privately owned and headquartered in Basel, Switzerland. Organic growth and a strong commitment to its employees are the cornerstones of Genedata’s 25-year history. With more than 300 employees and offices strategically located throughout Europe, the USA, and Asia, Genedata works closely with the leading institutions in the industry to help them deliver innovative biotherapeutics, vaccines, and cell & gene therapies to patients more quickly. Today, over 200 R&D institutions rely on the Genedata Biopharma Platform, including all top-25 biopharma companies worldwide.
Genedata transforms data into intelligence with innovative software solutions that incorporate extensive biopharma R&D domain knowledge. Multinational biopharmaceutical organizations and cutting-edge biotechs around the globe rely on Genedata to digitalize and automate data-rich and complex R&D processes. From early discovery all the way to the clinic, Genedata solutions help maximize the ROI in R&D expenditure. Founded in 1997, Genedata is headquartered in Basel, Switzerland with additional offices in Boston, London, Munich, San Francisco, Singapore, and Tokyo.
LinkedIn | Twitter | YouTube
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
All product and service names mentioned are the trademarks of their respective companies.